<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Geroscience Interventions MCDA Ranking</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
            line-height: 1.6;
            color: #2c3e50;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            min-height: 100vh;
        }

        .container {
            max-width: 1400px;
            margin: 0 auto;
            padding: 20px;
        }

        .header {
            text-align: center;
            margin-bottom: 15px;
            color: white;
        }

        .header h1 {
            font-size: 2.2em;
            margin-bottom: 5px;
            text-shadow: 2px 2px 4px rgba(0,0,0,0.3);
        }

        .header p {
            font-size: 1.1em;
            opacity: 0.9;
            max-width: 800px;
            margin: 0 auto;
        }

        .main-content {
            display: grid;
            grid-template-columns: 350px 1fr;
            gap: 20px;
            align-items: start;
        }

        .controls-panel {
            background: white;
            border-radius: 15px;
            padding: 25px;
            box-shadow: 0 10px 30px rgba(0,0,0,0.1);
            position: sticky;
            top: 20px;
        }

        .controls-panel h2 {
            margin-bottom: 20px;
            color: #2c3e50;
            font-size: 1.4em;
            border-bottom: 2px solid #3498db;
            padding-bottom: 10px;
        }

        .weight-control {
            margin-bottom: 20px;
            padding: 15px;
            background: #f8f9fa;
            border-radius: 8px;
            border-left: 4px solid #3498db;
        }

        .weight-control label {
            display: block;
            font-weight: 600;
            margin-bottom: 8px;
            color: #2c3e50;
        }

        .weight-input-container {
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .weight-control input[type="range"] {
            flex: 1;
            height: 8px;
            border-radius: 4px;
            background: #ddd;
            outline: none;
            appearance: none;
        }

        .weight-control input[type="range"]::-webkit-slider-thumb {
            appearance: none;
            width: 20px;
            height: 20px;
            border-radius: 50%;
            background: #3498db;
            cursor: pointer;
            border: 2px solid white;
            box-shadow: 0 2px 4px rgba(0,0,0,0.2);
        }

        .weight-value {
            font-weight: bold;
            color: #3498db;
            min-width: 40px;
            text-align: center;
        }

        .preset-buttons {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 10px;
            margin-top: 20px;
        }

        .preset-btn {
            padding: 10px 15px;
            border: none;
            border-radius: 6px;
            background: #3498db;
            color: white;
            cursor: pointer;
            font-weight: 600;
            transition: all 0.3s ease;
        }

        .preset-btn:hover {
            background: #2980b9;
            transform: translateY(-2px);
        }

        .results-panel {
            background: white;
            border-radius: 15px;
            padding: 15px;
            box-shadow: 0 10px 30px rgba(0,0,0,0.1);
        }

        .results-panel h2 {
            margin-bottom: 10px;
            color: #2c3e50;
            font-size: 1.4em;
            border-bottom: 2px solid #e74c3c;
            padding-bottom: 8px;
        }

        .ranking-table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 10px;
            background: white;
            border-radius: 8px;
            overflow: hidden;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
        }

        .ranking-table th {
            background: linear-gradient(135deg, #3498db, #2980b9);
            color: white;
            padding: 8px 6px;
            text-align: left;
            font-weight: 600;
            font-size: 0.85em;
        }

        .ranking-table td {
            padding: 6px 6px;
            border-bottom: 1px solid #ecf0f1;
            font-size: 0.85em;
        }

        .ranking-table tr:hover {
            background: #f8f9fa;
        }

        .rank-cell {
            text-align: center;
            font-weight: bold;
            color: #e74c3c;
            width: 50px;
        }

        .intervention-cell {
            font-weight: 600;
            color: #2c3e50;
            width: 250px;
            min-width: 250px;
        }

        .score-cell {
            text-align: center;
            color: #7f8c8d;
            width: 80px;
            cursor: pointer;
            transition: all 0.2s ease;
        }

        .score-cell:hover {
            background: #3498db;
            color: white;
            transform: scale(1.05);
        }

        .weighted-score-cell {
            text-align: center;
            font-weight: bold;
            color: #27ae60;
            width: 100px;
        }

        .top-3 {
            background: linear-gradient(90deg, #fff3cd, #ffffff);
            border-left: 4px solid #ffc107;
        }

        .warning {
            background: #fff3cd;
            border: 1px solid #ffeaa7;
            border-radius: 6px;
            padding: 8px;
            margin-bottom: 10px;
            color: #856404;
            font-size: 0.85em;
        }

        .total-weight {
            font-weight: bold;
            margin-top: 15px;
            padding: 10px;
            background: #e8f5e8;
            border-radius: 6px;
            text-align: center;
        }

        @media (max-width: 1200px) {
            .main-content {
                grid-template-columns: 1fr;
            }
            
            .controls-panel {
                position: static;
            }
        }

        @media (max-width: 768px) {
            .ranking-table {
                font-size: 0.8em;
            }
            
            .ranking-table th,
            .ranking-table td {
                padding: 8px 5px;
            }
            
            .intervention-cell {
                max-width: 150px;
            }
            
            .preset-buttons {
                grid-template-columns: 1fr;
            }
        }

        /* Modal Styles */
        .modal {
            display: none;
            position: fixed;
            z-index: 1000;
            left: 0;
            top: 0;
            width: 100%;
            height: 100%;
            background-color: rgba(0,0,0,0.5);
            backdrop-filter: blur(3px);
        }

        .modal-content {
            background-color: white;
            margin: 5% auto;
            padding: 30px;
            border-radius: 15px;
            width: 80%;
            max-width: 700px;
            max-height: 80vh;
            overflow-y: auto;
            box-shadow: 0 15px 35px rgba(0,0,0,0.2);
            position: relative;
        }

        .modal-header {
            border-bottom: 2px solid #3498db;
            padding-bottom: 15px;
            margin-bottom: 20px;
        }

        .modal-header h2 {
            color: #2c3e50;
            margin: 0;
            font-size: 1.5em;
        }

        .modal-header h3 {
            color: #7f8c8d;
            margin: 5px 0 0 0;
            font-size: 1.1em;
            font-weight: normal;
        }

        .close {
            color: #aaa;
            float: right;
            font-size: 28px;
            font-weight: bold;
            cursor: pointer;
            position: absolute;
            right: 20px;
            top: 15px;
        }

        .close:hover {
            color: #e74c3c;
        }

        .evidence-content {
            line-height: 1.7;
            color: #34495e;
        }

        .evidence-content h4 {
            color: #2c3e50;
            margin-top: 20px;
            margin-bottom: 10px;
            font-size: 1.1em;
        }

        .evidence-content ul {
            padding-left: 20px;
        }

        .evidence-content li {
            margin-bottom: 8px;
        }

        .score-badge {
            display: inline-block;
            background: #3498db;
            color: white;
            padding: 4px 8px;
            border-radius: 4px;
            font-weight: bold;
            margin-bottom: 15px;
        }
        
        .references {
            margin-top: 15px;
            padding-top: 10px;
            border-top: 1px solid #ecf0f1;
            font-size: 0.9em;
            color: #7f8c8d;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="header">
            <h1>Geroscience Intervention Calculator</h1>
            <p>Explore how different strategic priorities affect the ranking of 30 leading geroscience interventions. Adjust domain weights to see real-time ranking changes based on your stakeholder perspective.</p>
        </div>

        <div class="main-content">
            <div class="controls-panel">
                <h2>Adjust Domain Weights</h2>
                
                <div class="weight-control">
                    <label for="lifespan">Preclinical Efficacy (Lifespan)</label>
                    <div class="weight-input-container">
                        <input type="range" id="lifespan" min="0" max="50" value="20" step="5">
                        <span class="weight-value" id="lifespan-value">20%</span>
                    </div>
                </div>

                <div class="weight-control">
                    <label for="healthspan">Preclinical Efficacy (Healthspan)</label>
                    <div class="weight-input-container">
                        <input type="range" id="healthspan" min="0" max="50" value="10" step="5">
                        <span class="weight-value" id="healthspan-value">10%</span>
                    </div>
                </div>

                <div class="weight-control">
                    <label for="conservation">Mechanism Conservation</label>
                    <div class="weight-input-container">
                        <input type="range" id="conservation" min="0" max="50" value="10" step="5">
                        <span class="weight-value" id="conservation-value">10%</span>
                    </div>
                </div>

                <div class="weight-control">
                    <label for="human">Human Trial Evidence</label>
                    <div class="weight-input-container">
                        <input type="range" id="human" min="0" max="50" value="20" step="5">
                        <span class="weight-value" id="human-value">20%</span>
                    </div>
                </div>

                <div class="weight-control">
                    <label for="safety">Safety & Tolerability</label>
                    <div class="weight-input-container">
                        <input type="range" id="safety" min="0" max="50" value="20" step="5">
                        <span class="weight-value" id="safety-value">20%</span>
                    </div>
                </div>

                <div class="weight-control">
                    <label for="biomarkers">Biomarker Availability</label>
                    <div class="weight-input-container">
                        <input type="range" id="biomarkers" min="0" max="50" value="10" step="5">
                        <span class="weight-value" id="biomarkers-value">10%</span>
                    </div>
                </div>

                <div class="weight-control">
                    <label for="cost">Cost & Accessibility</label>
                    <div class="weight-input-container">
                        <input type="range" id="cost" min="0" max="50" value="10" step="5">
                        <span class="weight-value" id="cost-value">10%</span>
                    </div>
                </div>

                <div class="total-weight" id="total-weight">Total Weight: 100%</div>

                <div class="preset-buttons">
                    <button class="preset-btn" onclick="setPreset('baseline')">Baseline</button>
                    <button class="preset-btn" onclick="setPreset('regulator')">Regulator</button>
                    <button class="preset-btn" onclick="setPreset('investor')">Investor</button>
                    <button class="preset-btn" onclick="setPreset('patient')">Patient</button>
                </div>
            </div>

            <div class="results-panel">
                <h2>Intervention Rankings</h2>
                <div id="warning" class="warning" style="display: none;">
                    ⚠️ Warning: Total weights don't equal 100%. Adjust sliders to reach 100% for accurate results.
                </div>
                
                <table class="ranking-table">
                    <thead>
                        <tr>
                            <th>Rank</th>
                            <th>Intervention</th>
                            <th>Lifespan</th>
                            <th>Healthspan</th>
                            <th>Conservation</th>
                            <th>Human</th>
                            <th>Safety</th>
                            <th>Biomarker</th>
                            <th>Cost</th>
                            <th>Weighted Score</th>
                        </tr>
                    </thead>
                    <tbody id="ranking-tbody">
                    </tbody>
                </table>
            </div>
        </div>

        <!-- Evidence Modal -->
        <div id="evidenceModal" class="modal">
            <div class="modal-content">
                <span class="close">&times;</span>
                <div class="modal-header">
                    <h2 id="modalTitle"></h2>
                    <h3 id="modalDomain"></h3>
                </div>
                <div id="modalBody" class="evidence-content">
                </div>
            </div>
        </div>
    </div>

    <script>
        // Evidence database
        const evidenceDatabase = {
            "Rapamycin/mTOR Inhibitors": {
                human: { score: 3, evidence: "Limited to small-scale studies; FDA-approved for transplant/cancer but early stage for geroscience. [References: Mannick JB, et al., 2014, Sci Transl Med, doi:10.1126/scitranslmed.3009892]" },
                safety: { score: 3, evidence: "FDA-approved but chronic use has moderate risks; high doses cause side effects like metabolic disturbances, stomatitis, and impaired wound healing. [References: Kaeberlein M, 2014, J Genet Genomics, doi:10.1016/j.jgg.2014.06.009]" },
                lifespan: { score: 4, evidence: "Gold standard evidence; NIA ITP confirmed significant median and maximal lifespan extension (up to 28%) in mice, even when started late in life. [References: Miller RA, Harrison, et al., 2014, Aging Cell, doi:10.1111/acel.12194; Harrison, D. E., et al., 2009, Nature, doi:10.1038/nature08221]" },
                healthspan: { score: 4, evidence: "Broad and potent benefits; delays cognitive decline, cardiac dysfunction, and immune senescence. [References: Bitto, A., et al., 2016, eLife, doi:10.7554/eLife.16351]" },
                conservation: { score: 5, evidence: "mTOR pathway is a master regulator of metabolism, ubiquitously and highly conserved from yeast to humans. [References: Saxton RA et al., 2017, Cell, doi:10.1016/j.cell.2017.02.004]" },
                biomarkers: { score: 3, evidence: "Direct, non-invasive biomarker pS6K can be measured in peripheral blood to show target engagement. [References: Liao, C. et al., 2012, Anticancer Research, PMID: 23060538]" },
                cost: { score: 3, evidence: "Moderate cost as a generic prescription drug. [References: Taber, D. J., et al., 2015, Current Opinion in Organ Transplantation, doi:10.1007/s40472-015-0052-y]" }
            },
            "Metformin": {
                human: { score: 3, evidence: "Vast indirect evidence from 60+ years of use; retrospective studies show lower all-cause mortality; prospective TAME trial is pending. [References: Barzilai N, et al., 2016, Cell Metab, doi:10.1016/j.cmet.2016.05.011]" },
                safety: { score: 5, evidence: "Unparalleled safety; on WHO Essential Medicines list, used by >150M people. Lactic acidosis is extremely rare. [References: Flory JH & Lipska K, 2019, JAMA, doi:10.1001/jama.2019.11708]" },
                lifespan: { score: 1, evidence: "Inconsistent; extends invertebrate lifespan, but multiple mouse studies (including NIA ITP) failed to show a significant/reproducible effect. [References: Strong, R., et al., 2016, Aging Cell, doi: 10.1111/acel.12496]" },
                healthspan: { score: 3, evidence: "More consistent than lifespan; improves physical performance, insulin sensitivity, and cognitive function in non-human primates. [References: Kodali, M., et al., 2021, Aging Cell, doi:10.1111/acel.13277]" },
                conservation: { score: 5, evidence: "Primary target, AMPK, is an exceptionally conserved central regulator of cellular energy metabolism across all eukaryotes. [References: Hardie DG, et al., 2012, Nat Rev Mol Cell Biol, doi:10.1038/nrm3368]" },
                biomarkers: { score: 4, evidence: "No direct geroscience-specific biomarker; relies on downstream metabolic outcomes (e.g., blood glucose, HbA1c). [References: Mueller, N. T., et al., 2021, Diabetes Care, doi:10.2337/dc20-2257]" },
                cost: { score: 5, evidence: "Highly accessible; available as a generic drug for pennies a day. [References: Soukas AA, et al., 2019, Annu Rev Med, doi:10.1146/annurev-med-050217-054734]" }
            },
            "Acarbose": {
                human: { score: 3, evidence: "Vast evidence from decades of use for diabetes/prediabetes; trials show it can prevent diabetes progression and reduce cardiovascular events. [References: DiNicolantonio JJ, et al., 2015, Open Heart, doi:10.1136/openhrt-2015-000327]" },
                safety: { score: 3, evidence: "Most common side effects are mild, transient GI issues. Standard dosing of 25-100 mg three times daily with meals causes gastrointestinal side effects, with 74% of patients reporting flatulence in a US trial. [References: Chiasson J, et al., 2003, JAMA, doi:10.1001/jama.290.4.486; STOP-NIDDM trial., 2003, JAMA, doi:10.1001/jama.290.4.486]" },
                lifespan: { score: 4, evidence: "Powerful and rigorously validated; NIA ITP found it extended median lifespan of male mice by 16-22% but 5% in females. [References: Harrison DE et al., 2014, Aging Cell, doi:10.1111/acel.12170; Harrison DE et al., 2019, Aging Cell, doi:10.1111/acel.12898]" },
                healthspan: { score: 4, evidence: "Notable benefits in mice including improved metabolic health, diminished liver degeneration, and beneficial modulation of gut microbiota. [References: Harrison DE et al., 2019, Aging Cell, doi:10.1111/acel.12898]" },
                conservation: { score: 4, evidence: "Primary mechanism (inhibition of alpha-glucosidase) and downstream effects on aging pathways (GLP-1, IGF-I) are highly conserved across mammals. [References: Harrison DE et al., 2019, Aging Cell, doi:10.1111/acel.12898]" },
                biomarkers: { score: 4, evidence: "Clinical effects are easily monitored using standard metabolic biomarkers like blood glucose and HbA1c. [References: Holman RR, et al., 2017, The Lancet Diabetes & Endocrinology, doi:10.1016/S2213-8587(17)30309-1]" },
                cost: { score: 5, evidence: "Highly accessible as a low-cost, widely available generic drug. [References: DiNicolantonio JJ, et al, 2015, Open Heart, doi:10.1136/openhrt-2015-000327]" }
            },
            "Epigenetic Reprogramming (OSK)": {
                human: { score: 2, evidence: "Entirely preclinical; first-in-human trials are beginning for specific indications like vision loss. [References: Yücel et al., 2024, Nature Communications, doi:10.1038/s41467-024-46020-5]" },
                safety: { score: 2, evidence: "Greatest concern; continuous expression can lead to teratoma formation/cancer; delivery via viral vectors carries risks. [References: Abad et al., 2013, Nature, doi:10.1038/nature12586]" },
                lifespan: { score: 5, evidence: "Most dramatic of all interventions; landmark study showed a 109% extension of remaining median lifespan in very old mice. [References: Cano Macip et al., 2024, Cellular Reprogramming, doi:10.1089/cell.2023.0072]" },
                healthspan: { score: 4, evidence: "Dramatic effects; significant improvement in frailty index and functional rejuvenation in specific tissues. [References: Cano Macip et al., 2024, Cellular Reprogramming, doi:10.1089/cell.2023.0072]" },
                conservation: { score: 4, evidence: "Based on the highly conserved nature of epigenetic regulation across all eukaryotic life. [References: Allis et al., 2016, Nature Reviews Genetics, doi:10.1038/nrg.2016.59]" },
                biomarkers: { score: 4, evidence: "Strength; DNA methylation-based epigenetic clocks provide a direct, quantitative measure of age reversal. [References: Horvath et al., 2018, Nature Reviews Genetics, doi:10.1038/s41576-018-0004-3]" },
                cost: { score: 1, evidence: "Prohibitively high; current delivery via viral vectors can cost over $1 million per dose. [References: Johnson et al., 2023, Nature Biotechnology, doi:10.1038/s41587-023-01760-5]" }
            },
            "GLP-1 Receptor Agonists": {
                human: { score: 4, evidence: "FDA-approved for diabetes/obesity. Large trials show reduced cardiovascular events. Semaglutide shown to reduce epigenetic age. [References: Marso SP, et al., 2016, N Engl J Med, doi:10.1056/NEJMoa1607141; Corley MJ, et al., 2024, Nat Commun, doi:10.1038/s41467-024-51772-5]" },
                safety: { score: 4, evidence: "Well-characterized profile, but side effects like nausea and vomiting can be significant. [References: Nauck MA, et al., 2021, Lancet, doi:10.1016/S0140-6736(21)00214-7]" },
                lifespan: { score: 3, evidence: "Demonstrates significant benefits for cardiovascular health, neuroprotection, and metabolic function in animal models. [References: Zheng Z et al., 2024, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-024-01931-z]" },
                healthspan: { score: 4, evidence: "Broad benefits: improved cardiovascular health, reduced hepatic fat, and potential neuroprotective effects. [References: Somineni HK, 2014, J Endocrinol, doi:10.1530/JOE-13-0532]" },
                conservation: { score: 4, evidence: "Highly conserved pathway in metabolic control (brain, heart, pancreas); mimics endogenous hormone GLP-1. [References: Drucker DJ, 2018, Cell Metab, doi:10.1016/j.cmet.2018.03.001]" },
                biomarkers: { score: 4, evidence: "Modulates validated epigenetic biomarkers of aging. Metabolic markers (blood glucose, body composition) also available. [References: Corley MJ, et al., 2025, medRxiv [Preprint], doi:10.1101/2025.07.09.25331038]" },
                cost: { score: 2, evidence: "High cost (~$12,000/year) and inaccessible for many. [References: Lin T, et al., 2024, Ann Intern Med, doi:10.7326/M23-2736]" }
            },
            "SGLT2 inhibitors": {
                human: { score: 4, evidence: "Exceptionally strong evidence; FDA-approved for heart failure and chronic kidney disease, preventing major age-related diseases. [References: Packer M, et al., 2020, N Engl J Med, doi:10.1056/NEJMoa2024816]" },
                safety: { score: 4, evidence: "Excellent profile; side effects (increased urination, genital infections) are manageable and often transient. [References: Neal B, et al., 2017, N Engl J Med, doi:10.1056/NEJMoa1611925]" },
                lifespan: { score: 3, evidence: "NIA ITP found a 14% median lifespan extension in male mice, but benefits appear confined to males. [References: Snyder JM, et al., 2023, Geroscience, doi:10.1007/s11357-022-00641-0]" },
                healthspan: { score: 4, evidence: "Broad benefits in animal models: reduced visceral fat, preserved lean mass, and mitigation of cardiomyopathy and kidney disease. [References: Snyder, J.M., et al., 2023, GeroScience, doi:10.1007/s11357-022-00641-0]" },
                conservation: { score: 4, evidence: "Pleiotropic and highly conserved mechanisms, including modulation of mTOR/AMPK and the NLRP3 inflammasome. [References: Yesilyurt-Dirican Z et al., 2025, npj Aging and Mechanisms of Disease, doi:10.1038/s41514-025-00227-y]" },
                biomarkers: { score: 4, evidence: "Reliably reduces inflammatory markers (IL-6) and clinical biomarkers of renal and heart failure (eGFR, NT-pro-BNP). [References: Yoo TT et al., 2025, Cardiovascular Diabetology, doi:10.1186/s12933-025-02777-7]" },
                cost: { score: 3, evidence: "Moderate cost as branded prescription drugs. [References: Aggarwal R et al., 2022, Circulation: Heart Failure, doi:10.1161/CIRCHEARTFAILURE.121.009099]" }
            },
            "NAD+ Restoration (NMN/NR)": {
                human: { score: 3, evidence: "Growing evidence from small trials confirms safety and efficacy in increasing blood NAD+ levels; reported benefits in muscle insulin sensitivity and walking endurance. [References: Yoshino M, et al., 2021, Science, doi:10.1126/science.abe9985]" },
                safety: { score: 4, evidence: "Excellent safety profile; multiple human trials found supplements to be safe and well-tolerated with no significant adverse events. [References: Berven et al., 2023, Nature Communications, doi:10.1038/s41467-023-43514-6]" },
                lifespan: { score: 3, evidence: "NR did not extend lifespan in NIA ITP mouse studies. NMN extended median lifespan by 8.5%, but only in female mice. [References: Harrison et al., 2021, Aging Cell, doi:10.1111/acel.13328]" },
                healthspan: { score: 3, evidence: "Stronger evidence than for lifespan; numerous rodent studies show amelioration of age-associated declines in insulin sensitivity, vascular health, and physical endurance. [References: Rajman et al., 2018, Cell Metabolism, doi:10.1016/j.cmet.2018.01.008]" },
                conservation: { score: 5, evidence: "Major strength; NAD+ metabolism is a fundamental and ancient biochemical process conserved across all domains of life. [References: Belenky et al., 2007, Trends in Biochemical Sciences, doi:10.1016/j.tibs.2006.11.006]" },
                biomarkers: { score: 4, evidence: "The primary goal of boosting NAD+ is a direct, measurable, and non-invasive biomarker via whole blood concentrations. [References: Martens CR, et al., 2018, Nat Commun, doi:10.1038/s41467-018-03421-7]" },
                cost: { score: 3, evidence: "Available as over-the-counter supplements at a moderate cost. [References: McDermott et al., 2024, Nature Communications, doi:10.1038/s41467-024-49092-5]" }
            },
            "Glutathione Precursors (GlyNAC)": {
                human: { score: 3, evidence: "Promising but preliminary; a small, placebo-controlled trial found it was safe and improved a suite of age-associated abnormalities. [References: Kumar P et al., 2023, Journals of Gerontology Series A, doi:10.1093/gerona/glac135]" },
                safety: { score: 4, evidence: "Human trial reported it was 'safe and well-tolerated' with 'no adverse events'. [References: Lizzo G et al., 2022, Frontiers in Aging, doi:10.3389/fragi.2022.852569]" },
                lifespan: { score: 3, evidence: "Limited direct studies, but individual components (glycine) have extended lifespan in mice. [References: Miller RA et al., 2019, Aging Cell, doi:10.1111/acel.12953]" },
                healthspan: { score: 3, evidence: "Improves a range of age-related defects in mice (oxidative stress, mitochondrial function, insulin resistance); also improved physical function in a human trial. [References: Kumar P et al., 2021, Clinical and Translational Medicine, doi:10.1002/ctm2.372]" },
                conservation: { score: 4, evidence: "Based on a fundamental and highly conserved biochemical process: replenishing glutathione to protect mitochondria from oxidative stress. [References: Marí M et al., 2020, Antioxidants, doi:10.3390/antiox9100909]" },
                biomarkers: { score: 3, evidence: "Major advantage; the primary goal of correcting glutathione deficiency can be reliably quantified in blood and muscle. [References: Kumar P et al., 2023, Journals of Gerontology Series A, doi:10.1093/gerona/glac135]" },
                cost: { score: 4, evidence: "Highly accessible as a low-cost nutritional supplement. [References: Sekhar RV et al., 2022, Antioxidants, doi:10.3390/antiox11010154]" }
            },
            "Senolytics (Dasatinib + Quercetin)": {
                human: { score: 3, evidence: "Preliminary; early-phase trials show reduced senescent cell burden and improved physical function in patients with specific diseases. [References: Hickson LJ et al., 2019, EBioMedicine, doi:10.1016/j.ebiom.2019.08.069]" },
                safety: { score: 3, evidence: "Key concern as Dasatinib is a powerful chemotherapy drug; long-term effects of intermittent dosing are unknown. [References: Rad AN et al., 2024, Current Drug Metabolism, doi:10.1016/j.mad.2023.111888]" },
                lifespan: { score: 3, evidence: "Positive but modest; pharmacological clearance with D+Q increased median lifespan in mice by ~6.3% in one key study. [References: Blagosklonny MV, 2021, Oncotarget, doi:10.18632/oncotarget.28049]" },
                healthspan: { score: 4, evidence: "Primary strength; broad and impressive effects, improving cardiovascular function, osteoporosis, physical, and cognitive performance. [References: Wyatt AW et al., 2021, Annual Review of Pharmacology and Toxicology, doi:10.1146/annurev-pharmtox-050120-105018]" },
                conservation: { score: 4, evidence: "Cellular senescence is a highly conserved biological process in vertebrates. [References: Davaapil H et al., 2017, Development, doi:10.1242/dev.138222]" },
                biomarkers: { score: 3, evidence: "Major barrier; lacks a simple, non-invasive biomarker. Assessment typically requires invasive tissue biopsies (p16INK4a, SA-β-gal). [References: Muthamil S et al., 2024, Advanced Biology, doi:10.1002/adbi.202400079]" },
                cost: { score: 2, evidence: "Likely to be high cost due to the inclusion of Dasatinib, a chemotherapy drug. [References: Rad AN et al., 2024, Current Drug Metabolism, doi:10.1016/j.mad.2023.111888]" }
            },
            "Alpha-ketoglutarate (AKG)": {
                human: { score: 2, evidence: "No human trial data for geroscience; a human trial assessing AKG's effect on biological age is in progress. [References: Sandalova E et al., 2023, Geroscience, doi:10.1007/s11357-023-00813-6]" },
                safety: { score: 4, evidence: "Considered Generally Recognized as Safe (GRAS) by the FDA; preclinical study in mice found no significant adverse effects. [References: Asadi Shahmirzadi A, et al., 2020, Cell Metab, doi:10.1016/j.cmet.2020.08.004]" },
                lifespan: { score: 3, evidence: "Consistently extends lifespan in invertebrates; key mouse study showed 12% median lifespan extension, more pronounced in females. [References: Asadi Shahmirzadi A, et al., 2020, Cell Metab, doi:10.1016/j.cmet.2020.08.004]" },
                healthspan: { score: 3, evidence: "Compresses morbidity in aged mice, improving frailty index by over 40% and enhancing physical function. [References: Asadi Shahmirzadi A, et al., 2020, Cell Metab, doi:10.1016/j.cmet.2020.08.004]" },
                conservation: { score: 4, evidence: "Highly conserved as a fundamental metabolite in the TCA cycle, contributing to metabolism, collagen synthesis, and epigenetic regulation. [References: Wu N et al., 2016, Biomolecules & Therapeutics, doi:10.4062/biomolther.2015.078]" },
                biomarkers: { score: 2, evidence: "No established geroscience-specific biomarker; plasma AKG levels are not a validated biomarker for its anti-aging effect. [References: Sandalova E et al., 2023, Geroscience, doi:10.1007/s11357-023-00813-6]" },
                cost: { score: 4, evidence: "Highly accessible; widely available as a low-cost over-the-counter supplement. [References: Demidenko O, et al., 2021, Aging (Albany NY), doi:10.18632/aging.203736]" }
            },
            "L-deprenyl": {
                human: { score: 3, evidence: "Vast indirect evidence from long-term use for Parkinson's disease; no clinical study on healthy human aging. [References: Jost WH et al., 2022, Journal of Neural Transmission, doi:10.1007/s00702-022-02465-w]" },
                safety: { score: 4, evidence: "Generally well-tolerated at low doses used for Parkinson's; high doses carry risk of interactions. [References: Wang K et al., 2023, Frontiers in Aging Neuroscience, doi:10.3389/fnagi.2023.1134472]" },
                lifespan: { score: 4, evidence: "Meta-analysis of 22 rodent studies showed significant and reproducible lifespan extension. [References: Bene MR et al., 2025, Ageing Research Reviews, doi:10.1016/j.arr.2025.102873]" },
                healthspan: { score: 3, evidence: "Neuroprotective effects; improves aspects of age-related hearing loss in mice; has antioxidant and anti-apoptotic effects. [References: Szepesy J et al., 2021, International Journal of Molecular Sciences, doi:10.3390/ijms22062853]" },
                conservation: { score: 4, evidence: "Conserved mechanism of irreversible inhibition of monoamine oxidase B (MAO-B), an enzyme in dopamine metabolism. [References: Tan YY et al., 2022, Journal of Parkinson's Disease, doi:10.3233/JPD-212976]" },
                biomarkers: { score: 3, evidence: "MAO-B activity and dopamine metabolites can be measured, but aging-specific biomarkers are limited. [References: Justice JN et al., 2018, GeroScience, doi:10.1007/s11357-018-0042-y]" },
                cost: { score: 4, evidence: "Low-cost and widely accessible as an approved, generic drug. [References: Dorsey ER et al., 2009, Neurology, doi:10.1212/WNL.0b013e3181ae7b04]" }
            },
            "Autophagy Inducers (Spermidine)": {
                human: { score: 2, evidence: "Early phases; small studies suggest improved cognitive skills in older adults, but larger trials are needed. [References: Wirth et al., 2018, Cortex, doi:10.1016/j.cortex.2018.09.014]" },
                safety: { score: 4, evidence: "Major advantage; excellent safety profile as a natural polyamine found in food; well-tolerated. [References: Schwarz et al., 2018, Aging (Albany NY), doi:10.18632/aging.101354]" },
                lifespan: { score: 3, evidence: "Prolongs lifespan in a wide array of organisms including yeast, flies, worms, and mice. [References: Eisenberg et al., 2016, Nature Medicine, doi:10.1038/nm.4222]" },
                healthspan: { score: 4, evidence: "Strong effects, particularly on cardiac and brain function; higher dietary intake correlated with lower incidence of cardiovascular diseases in humans. [References: LaRocca et al., 2013, Mechanisms of Ageing and Development, doi:10.1016/j.mad.2013.04.004]" },
                conservation: { score: 5, evidence: "Highly conserved; induces autophagy, a fundamental cellular cleanup process, by inhibiting the acetyltransferase EP300. [References: Pietrocola et al., 2015, Cell Death & Differentiation, doi:10.1038/cdd.2014.215]" },
                biomarkers: { score: 2, evidence: "Key challenge; lacks a simple, routine biomarker for measuring autophagy in a clinical setting. [References: Klionsky et al., 2021, Autophagy (Guidelines, 4th ed.), doi:10.1080/15548627.2020.1797280]" },
                cost: { score: 4, evidence: "Highly accessible due to low cost and widespread availability as an over-the-counter supplement. [References: Madeo et al., 2018, Autophagy Reviews (Perspective), doi: 10.1126/science.aan2788]" }
            },
            "Natural Senolytics (Fisetin)": {
                human: { score: 2, evidence: "Early stages; trials are underway for frailty, but no definitive results for an anti-aging indication exist. [References: Yousefzadeh MJ et al., 2018, eBioMedicine, doi:10.1016/j.ebiom.2018.09.015]" },
                safety: { score: 4, evidence: "Major advantage; as a natural compound in food, it is generally considered safe for human use. [References: Yousefzadeh MJ et al., 2018, eBioMedicine, doi:10.1016/j.ebiom.2018.09.015]" },
                lifespan: { score: 3, evidence: "Extended mouse lifespan by ~10% in one study, but contested by NIA ITP testing which found no effect. [References: Yousefzadeh MJ, et al., 2018, EBioMedicine, doi:10.1016/j.ebiom.2018.09.015]" },
                healthspan: { score: 3, evidence: "Benefits are broad-acting; studies show it can prevent cognitive decline, reduce inflammation, and improve metabolic health in animal models. [References: Pal HC et al., 2016, Advances in Experimental Medicine and Biology, doi:10.1007/978-3-319-41334-1_10]" },
                conservation: { score: 4, evidence: "Acts as a senolytic by clearing senescent cells and inhibiting SASP; also modulates highly conserved PI3K/AKT/mTOR and SIRT1 pathways. [References: Tavenier et al., 2024, Mechanisms of Ageing and Development, doi:10.1016/j.mad.2024.111995]" },
                biomarkers: { score: 2, evidence: "Significant challenge; lacks a simple, non-invasive biomarker for senescent cell burden. [References: Ogrodnik M et al., 2024, Cell, doi:10.1016/j.cell.2024.05.059]" },
                cost: { score: 4, evidence: "Highly accessible due to low cost and widespread availability as an over-the-counter supplement. [References: Yousefzadeh MJ, et al., 2018, EBioMedicine, doi:10.1016/j.ebiom.2018.09.015]" }
            },
            "Gut Microbiome Modulation": {
                human: { score: 3, evidence: "Probiotics show moderate effects on immune function in older adults; one pilot trial of a symbiotic reversed biological age. [References: Fitzgerald et al., 2021, Aging (Albany NY), doi:10.18632/aging.202913]" },
                safety: { score: 4, evidence: "Excellent safety for diet-based modulation and many probiotics; FMT carries risks of complications and pathogen transmission. [References: DeFilipp et al., 2019, New England Journal of Medicine, doi:10.1056/NEJMoa1910437]" },
                lifespan: { score: 3, evidence: "Fecal microbiota transplantation (FMT) from young to old mice extends lifespan and improves healthspan. [References: Bárcena et al., 2019, Nature Medicine, doi:10.1038/s41591-019-0504-5]" },
                healthspan: { score: 3, evidence: "Can reduce chronic inflammation ('inflammaging'), improve metabolic health, and alleviate depression/anxiety-like behaviors in aged mice. [References: Parker et al., 2022, Microbiome, doi:10.1186/s40168-022-01243-w]" },
                conservation: { score: 4, evidence: "The interaction between a host and its microbial ecosystem is a highly conserved biological mechanism. [References: Wilde et al., 2024, Science, doi:10.1126/science.adi3338]" },
                biomarkers: { score: 3, evidence: "Microbiota composition can be assessed, but these are not yet standardized biomarkers for routine geroscience trials. [References: Xu et al., 2024, Microbiome Research Reports, doi:10.20517/mrr.2023.68]" },
                cost: { score: 4, evidence: "Lifestyle changes and many probiotics are low-cost; however, therapies like FMT can be very expensive. [References: Wynn et al., 2023, Cureus, doi:10.7759/cureus.35116]" }
            },
            "Mitochondria (Urolithin A)": {
                human: { score: 3, evidence: "Promising but preliminary; human trials report positive outcomes in muscle strength and endurance. [References: Liu et al., 2022, JAMA Network Open, doi:10.1001/jamanetworkopen.2021.44279]" },
                safety: { score: 4, evidence: "Strong safety profile; no serious adverse events reported in human trials. [References: Andreux et al., 2019, Nature Metabolism, doi:10.1038/s42255-019-0073-4]" },
                lifespan: { score: 3, evidence: "Limited but promising; one key study found a 45% increase in lifespan in C. elegans and improved rodent healthspan. [References: Ryu et al., 2016, Nature Medicine, doi:10.1038/nm.4132]" },
                healthspan: { score: 4, evidence: "Broad benefits including anti-inflammatory, antioxidant, and anti-aging properties; improves muscle function and delays fatigue in animal models. [References: D'Amico et al., 2021, Trends in Molecular Medicine, doi:10.1016/j.molmed.2021.04.009]" },
                conservation: { score: 4, evidence: "Based on activating mitophagy, a highly conserved cellular cleanup process for removing damaged mitochondria. [References: Faitg et al., 2023, Calcified Tissue International, doi:10.1007/s00223-023-01145-5]" },
                biomarkers: { score: 3, evidence: "A challenge; a simple, non-invasive biomarker of its primary effect (mitophagy) is not yet routinely available, but plasma acylcarnitines have been used. [References: Liu et al., 2022, JAMA Network Open, doi:10.1001/jamanetworkopen.2021.44279]" },
                cost: { score: 3, evidence: "Barrier; branded, clinically-tested formulations are often expensive. [References: Kuerec et al., 2024, Ageing Research Reviews, doi:10.1016/j.arr.2024.102406]" }
            },
            "Anti-Inflammatory Therapies": {
                human: { score: 3, evidence: "A large trial (ASPREE) found daily low-dose aspirin did not prolong healthy living in older adults and increased bleeding risk. [References: McNeil et al., 2018, New England Journal of Medicine, doi:10.1056/NEJMoa1800722]" },
                safety: { score: 3, evidence: "Significant risks of side effects, including gastrointestinal bleeding and kidney problems. [References: Harirforoosh et al., 2013, Journal of Pharmacy & Pharmaceutical Sciences, doi:10.18433/J3VW2F]" },
                lifespan: { score: 2, evidence: "Conflicting data; one meta-analysis showed lifespan increase, but the NIA ITP study found no increase for aspirin in mice. [References: Strong et al., 2008, Aging Cell, doi:10.1111/j.1474-9726.2008.00414.x]" },
                healthspan: { score: 3, evidence: "Reducing inflammation would have broad benefits; drugs like NSAIDs also activate NRF2, a master regulator of cellular homeostasis. [References: Eisenstein et al., 2022, Immunity, doi:10.1016/j.immuni.2022.04.015]" },
                conservation: { score: 4, evidence: "The inflammatory response is a deeply conserved biological mechanism. [References: Medzhitov, 2008, Nature, doi:10.1038/nature07201]" },
                biomarkers: { score: 4, evidence: "Inflammatory markers like IL-6 and hs-CRP are routinely measured in clinical practice, making it easy to track effects. [References: Ridker, 2016, Circulation Research, doi:10.1161/CIRCRESAHA.115.306656]" },
                cost: { score: 4, evidence: "Highly accessible; many drugs are available over-the-counter and are very low cost. [References: Grootendorst et al., 2005, Health Services Research, doi:10.1111/j.1475-6773.2005.00420.x]" }
            },
            "Plasma dilution/apheresis": {
                human: { score: 3, evidence: "A single human trial showed therapeutic plasma exchange (TPE) significantly lowered biological age, providing a powerful proof-of-concept that needs replication. [References: Kim et al., 2022, GeroScience, doi:10.1007/s11357-022-00645-w]" },
                safety: { score: 3, evidence: "TPE is an FDA-approved procedure with a known and generally well-managed safety profile; most side effects are mild-to-moderate. [References: Shemin et al., 2007, Journal of Clinical Apheresis, doi:10.1002/jca.20143]" },
                lifespan: { score: 2, evidence: "A preclinical study showed that diluting old plasma was more effective than adding young plasma at rejuvenating multiple tissues in mice. [References: Mehdipour et al., 2020, Aging (Albany NY), doi:10.18632/aging.103418]" },
                healthspan: { score: 3, evidence: "Benefits include rejuvenation of muscle and liver, and promotion of better hippocampal neurogenesis in mice. [References: Mehdipour et al., 2020, Aging (Albany NY), doi:10.18632/aging.103418]" },
                conservation: { score: 4, evidence: "Based on the conserved concept that aging is driven by an accumulation of detrimental molecular factors in the blood. [References: Lagunas-Rangel et al., 2024, npj Aging Mechanisms of Disease, doi:10.1038/s41514-024-00166-0]" },
                biomarkers: { score: 3, evidence: "Epigenetic clocks provide a direct and quantifiable measure of biological age reversal, used successfully in a human trial. [References: Fuentealba et al., 2025, Aging Cell, doi:10.1111/acel.70103]" },
                cost: { score: 2, evidence: "Significant barrier; cost is high, making it highly inaccessible for broad preventative use. [References: Winters et al., 2011, BMC Health Services Research, doi:10.1186/1472-6963-11-101]" }
            },
            "Steroids (17α-estradiol)": {
                human: { score: 1, evidence: "Non-existent for a longevity intervention. [References: Stout et al., 2023, GeroScience, doi:10.1007/s11357-023-00767-9]" },
                safety: { score: 3, evidence: "Limited safety context from topical use for hair loss; long-term systemic safety in healthy humans is largely unknown. [References: Kim et al., 2012, Annals of Dermatology, doi:10.5021/ad.2012.24.3.295]" },
                lifespan: { score: 4, evidence: "19% median lifespan extension in male mice in an NIA ITP study; effect was highly sex-specific. [References: Harrison et al., 2021, Aging Cell, doi:10.1111/acel.13328]" },
                healthspan: { score: 3, evidence: "Prevented age-associated sarcopenia and fat gain in male mice without feminizing side effects; improved late-life physical function. [References: Garratt et al., 2019, Aging Cell, doi:10.1111/acel.12920]" },
                conservation: { score: 4, evidence: "Unique non-genomic anti-aging mechanism via membrane estrogen receptors, activating protein kinase cascades and producing epigenetic effects. [References: Arnal et al., 2017, Physiological Reviews, doi:10.1152/physrev.00024.2016]" },
                biomarkers: { score: 2, evidence: "No established biomarkers for its geroscience effects exist. [References: Justice et al., 2018, GeroScience, doi:10.1007/s11357-018-0042-y]" },
                cost: { score: 3, evidence: "Likely inexpensive to produce, but would require a prescription and monitoring. [References: Ramos et al., 2023, Anais Brasileiros de Dermatologia, doi:10.1016/j.abd.2022.09.006]" }
            },
            "Stem Cell Therapy": {
                human: { score: 3, evidence: "Well-established for hematopoietic disorders, but lacks evidence for a broad anti-aging indication. Some early trials show promise for frailty. [References: Tompkins et al., 2017, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, doi:10.1093/gerona/glx137]" },
                safety: { score: 3, evidence: "Key consideration; autologous cells reduce rejection risk, but the procedure still carries risks of infection and other complications. [References: Waszczuk-Gajda et al., 2022, Journal of Clinical Medicine, doi:10.3390/jcm11123541]" },
                lifespan: { score: 2, evidence: "A study found that transplanting hematopoietic stem cells from young to old mice extended lifespan by ~10%. [References: Guderyon et al., 2020, Aging Cell, doi:10.1111/acel.13110]" },
                healthspan: { score: 4, evidence: "Broad benefits; can regenerate damaged tissue, modulate the immune system, and reduce inflammation. [References: Montserrat-Vazquez et al., 2022, npj Regenerative Medicine, doi:10.1038/s41536-022-00275-y]" },
                conservation: { score: 4, evidence: "Highly conserved; stem cells play a fundamental role in tissue repair and regeneration across all complex life forms. [References: Bideau et al., 2021, Cellular and Molecular Life Sciences, doi:10.1007/s00018-021-03760-7]" },
                biomarkers: { score: 2, evidence: "No single, non-invasive biomarker exists for systemic anti-aging effects; efficacy measured by functional outcomes. [References: Moqri et al., 2023, Cell, doi:10.1016/j.cell.2023.08.003]" },
                cost: { score: 1, evidence: "Prohibitively high due to specialized collection, processing, and administration. [References: Preussler et al., 2012, Biology of Blood and Marrow Transplantation (now Transplantation and Cellular Therapy), doi:10.1016/j.bbmt.2012.04.001]" }
            },
            "Xenotransplantation": {
                human: { score: 2, evidence: "Earliest stages; the first successful transplants of genetically modified pig kidneys into living human patients occurred in 2024. [References: Kawai et al., 2025, New England Journal of Medicine, doi:10.1056/NEJMoa2412747]" },
                safety: { score: 2, evidence: "Sizable concerns, including risk of hyperacute rejection and transmission of unknown zoonotic pathogens. [References: Fishman & Mueller, 2024, Emerging Infectious Diseases, doi:10.3201/eid3007.240273]" },
                lifespan: { score: 4, evidence: "Not a preventative anti-aging intervention, but high potential to extend life by restoring organ function. [References: Riella, 2025, Journal of the American Society of Nephrology, doi:10.1681/ASN.0000000581]" },
                healthspan: { score: 4, evidence: "Benefit is absolute for a person with a failing organ, potentially saving or extending a person's life. [References: Kawai et al., 2025, New England Journal of Medicine, doi:10.1056/NEJMoa2412747]" },
                conservation: { score: 3, evidence: "Underlying mechanisms of organ function and immune response are conserved, but significant physiological differences exist between pigs and humans. [References: Sykes & Sachs, 2022, Nature Reviews Nephrology, doi:10.1038/s41581-022-00624-6]" },
                biomarkers: { score: 3, evidence: "Organ function and rejection markers can be monitored using standard transplant protocols. [References: Westphal & Mannon, 2025, American Journal of Kidney Diseases, doi:10.1053/j.ajkd.2024.07.018]" },
                cost: { score: 1, evidence: "Prohibitively high; a last-resort procedure requiring lifelong surveillance. [References: Anderson & Locke, 2024, Current Transplantation Reports, doi:10.1007/s40472-024-00455-3]" }
            },
            "Telomere Extension Therapies": {
                human: { score: 2, evidence: "A gene therapy trial for telomere biology disorders showed sustained telomere elongation without major safety concerns. [References: Myers KC et al., 2025, NEJM Evidence, doi:10.1056/EVIDoa2400252]" },
                safety: { score: 2, evidence: "Primary concern is cancer risk, as uncontrolled telomerase expression can immortalize cells; transient modified RNA technique mitigates this risk. [References: Ramunas J et al., 2015, FASEB Journal, doi:10.1096/fj.14-259531]" },
                lifespan: { score: 3, evidence: "Modified RNA therapy lengthened telomeres in cultured human cells, allowing them to divide more times. [References: Ramunas J et al., 2015, FASEB Journal, doi:10.1096/fj.14-259531]" },
                healthspan: { score: 3, evidence: "Modified RNA therapy increased proliferation of cultured human muscle and skin cells, 'turning back the clock' on a cellular level. [References: Ramunas J et al., 2015, FASEB Journal, doi:10.1096/fj.14-259531]" },
                conservation: { score: 4, evidence: "Based on a fundamental and conserved biological process involving telomeres and telomerase ensuring chromosome integrity. [References: Blackburn EH et al., 2006, Nature Medicine, doi:10.1038/nm1006-1133]" },
                biomarkers: { score: 3, evidence: "Telomere length itself is a direct and precise biomarker of the intervention's effect. [References: Fasching CL, 2018, Critical Reviews in Clinical Laboratory Sciences, doi:10.1080/10408363.2018.1504274]" },
                cost: { score: 1, evidence: "Prohibitively high; early gene therapy trials were exceptionally expensive. [References: Naddaf M, 2022, Nature (News Feature), doi:10.1038/d41586-022-04327-7]" }
            },
            "Gene Therapy": {
                human: { score: 1, evidence: "Entirely preclinical for a geroscience indication. [References: Kroemer et al., 2025, Cell, doi:10.1016/j.cell.2025.03.011]" },
                safety: { score: 2, evidence: "Most significant barrier; use of viral vectors (AAVs) carries risks of off-target effects and life-threatening immune reactions. [References: Ronzitti et al., 2020, Frontiers in Immunology, doi:10.3389/fimmu.2020.00670]" },
                lifespan: { score: 3, evidence: "Study showed elevating Klotho protein levels via gene therapy extended mouse lifespan by up to 30%. [References: Kurosu et al., 2005, Science, doi:10.1126/science.1112766]" },
                healthspan: { score: 3, evidence: "Dramatic benefits including improved physical and cognitive function, larger muscle fibers, better bone density, and stimulated neurogenesis. [References: Roig-Soriano et al., 2025, Molecular Therapy, doi:10.1016/j.ymthe.2025.02.030]" },
                conservation: { score: 4, evidence: "Based on the fundamental principle of gene regulation; the Klotho gene is a conserved aging-suppressing gene in mammals. [References: Xu et al., 2015, Endocrine Reviews, doi:10.1210/er.2013-1079]" },
                biomarkers: { score: 3, evidence: "Strength; Klotho protein levels can be directly measured, and its effects on functional and epigenetic markers can be tracked. [References: Devaraj et al., 2012, American Journal of Clinical Pathology, doi:10.1309/AJCPGPMAF7SFRBO4]" },
                cost: { score: 1, evidence: "Prohibitively inaccessible; among the most expensive medical interventions, with prices in the millions of dollars per dose. [References: Naddaf, 2022, Nature (news feature), doi:10.1038/d41586-022-04327-7]" }
            },
            "Exosome Therapy": {
                human: { score: 2, evidence: "Limited and largely focused on aesthetic applications; no large-scale human data for systemic anti-aging effects. [References: Gupta et al., 2023, Journal of Cosmetic Dermatology, doi:10.1111/jocd.15869]" },
                safety: { score: 3, evidence: "Advantage over stem cells as they are acellular, reducing risks like embolism; generally well-tolerated, but long-term systemic safety is unknown. [References: Xu et al., 2025, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-025-02312-w]" },
                lifespan: { score: 2, evidence: "Limited direct lifespan data, but has regenerative properties with a long-term vision for healthspan and longevity. A recent study reports ~12% median lifespan extension in aged mice treated with young plasma sEVs. [References: Chen et al., 2024, Nature Aging, doi:10.1038/s43587-024-00612-4]" },
                healthspan: { score: 2, evidence: "Possess regenerative, immunomodulatory, and anti-inflammatory properties; can stimulate collagen synthesis and promote muscle regeneration. [References: Sanz-Ros et al., 2022, Science Advances, doi:10.1126/sciadv.abq2226]" },
                conservation: { score: 3, evidence: "Based on intercellular communication, a fundamental and conserved biological process. [References: Kalluri et al., 2020, Science, doi:10.1126/science.aau6977]" },
                biomarkers: { score: 2, evidence: "Efficacy is often measured by downstream functional outcomes and changes in exosome cargo (miRNAs). [References: Arora et al., 2025, Scientific Reports, doi:10.1038/s41598-025-15814-y]" },
                cost: { score: 2, evidence: "Prohibitive cost, making it a highly restricted therapy. [References: Wang et al., 2024, Clinical and Translational Science, doi:10.1111/cts.13904]" }
            },
            "Chemical Reprogramming": {
                human: { score: 1, evidence: "No human trial data for geroscience indication. [References: Wang J et al., 2023, Cell Stem Cell, doi:10.1016/j.stem.2023.08.001]" },
                safety: { score: 2, evidence: "Unproven for systemic use; small molecules are safer than transgenic methods as they don't integrate into the genome, but systemic use requires thorough testing. [References: Kim Y et al., 2020, Experimental & Molecular Medicine, doi:10.1038/s12276-020-0383-3]" },
                lifespan: { score: 3, evidence: "No direct evidence in mammals; one study showed lifespan and healthspan extension in C. elegans. [References: Schoenfeldt L et al., 2025, EMBO Molecular Medicine, doi:10.1038/s44321-025-00265-9]" },
                healthspan: { score: 2, evidence: "Lacks direct healthspan data for mammalian models, but reverses cellular aging markers in human cells. [References: Yang JH et al., 2023, Aging (Albany NY), doi:10.18632/aging.204896]" },
                conservation: { score: 4, evidence: "Strong theoretical basis; targets highly conserved fundamental mechanisms like DNA methylation and histone modification. [References: Allis CD et al., 2016, Nature Reviews Genetics, doi:10.1038/nrg.2016.59]" },
                biomarkers: { score: 4, evidence: "Availability of epigenetic clocks provides a direct and quantitative biomarker for measuring its effects. [References: Horvath S et al., 2018, Nature Reviews Genetics, doi:10.1038/s41576-018-0004-3]" },
                cost: { score: 2, evidence: "Likely to be high-cost and require specialist administration, though potentially cheaper than viral vectors. [References: Kim Y et al., 2020, Experimental & Molecular Medicine, doi:10.1038/s12276-020-0383-3]" }
            },
            "Chloroquine": {
                human: { score: 2, evidence: "Large body of data from malaria/autoimmune use, but none for a geroscience indication. [References: Nirk EL et al., 2020, EMBO Molecular Medicine, doi:10.15252/emmm.202012476]" },
                safety: { score: 2, evidence: "Major barrier; substantial side effect profile including potential neuromyopathy, retinopathy, and serious heart rhythm problems. [References: Bansal P et al., 2021, Annals of Medicine, doi:10.1080/07853890.2020.1839959]" },
                lifespan: { score: 2, evidence: "Modest lifespan extension in middle-aged male mice; effects appear to be sex and age-dependent. [References: Doeppner TR et al., 2022, Aging (Albany NY), doi:10.18632/aging.204069]" },
                healthspan: { score: 2, evidence: "Detrimental; emulates aging on the neuromuscular system, causing denervation and decreased muscle force in mice. [References: Saldarriaga CA et al., 2023, Journal of Applied Physiology, doi:10.1152/japplphysiol.00365.2023]" },
                conservation: { score: 4, evidence: "Conserved across eukaryotes; inhibits autophagy by preventing autophagosome-lysosome fusion. [References: Mauthe M et al., 2018, Autophagy, doi:10.1080/15548627.2018.1474314]" },
                biomarkers: { score: 2, evidence: "No established, non-invasive biomarkers exist for its geroscience effects. [References: Klionsky DJ et al., 2021, Autophagy (Guidelines), doi:10.1080/15548627.2020.1797280]" },
                cost: { score: 4, evidence: "Low cost as a generic drug, but this is irrelevant given its detrimental effects. [References: Kamat S et al., 2021, Frontiers in Pharmacology, doi:10.3389/fphar.2021.576093]" }
            },
            "Young Blood Plasma and Parabiosis": {
                human: { score: 2, evidence: "Very limited; a small trial in Alzheimer's patients showed some functional but no cognitive benefits; FDA cautioned against it as 'unproven'. [References: Sha et al., 2019, JAMA Neurology, doi:10.1001/jamaneurol.2018.3288]" },
                safety: { score: 2, evidence: "Significant concerns, including the risk of infection and adverse immune reactions. [References: Pandey et al., 2012, Transfusion, doi:10.1111/j.1537-2995.2012.03663.x]" },
                lifespan: { score: 2, evidence: "Lack of specific data on lifespan extension from parabiosis experiments, with some studies showing no benefit. [References: Yankova et al., 2022, Rejuvenation Research, doi:10.1089/rej.2022.0029]" },
                healthspan: { score: 3, evidence: "Early experiments suggested rejuvenation of aged tissues, but later studies showed old blood was more detrimental than young blood was beneficial. [References: Rebo et al., 2016, Nature Communications, doi:10.1038/ncomms13363]" },
                conservation: { score: 3, evidence: "Age-related changes in the blood and their effects on tissues are conserved across mammals. [References: Lagunas-Rangel, 2024, npj Aging and Mechanisms of Disease, doi:10.1038/s41514-024-00166-0]" },
                biomarkers: { score: 2, evidence: "Age-related changes in plasma proteins and metabolites have been investigated as potential biomarkers. [References: Lehallier et al., 2019, Nature Medicine, doi:10.1038/s41591-019-0673-2]" },
                cost: { score: 1, evidence: "Expensive with questionable benefits; limited availability and regulatory restrictions. [References: Hofmann, 2018, Transfusion Medicine and Hemotherapy, doi:10.1159/000481828]" }
            },
            "Immunotherapy for Senescent Cells": {
                human: { score: 1, evidence: "Purely preclinical for geroscience, with no human trials underway. [References: Lelarge et al., 2024, npj Aging, doi:10.1038/s41514-024-00138-4]" },
                safety: { score: 2, evidence: "Entirely unknown; risk of off-target effects and autoimmune reactions is a major concern. [References: Lelarge et al., 2024, npj Aging, doi:10.1038/s41514-024-00138-4]" },
                lifespan: { score: 2, evidence: "Preclinical studies show a senolytic CAR-T cell therapy can improve aging phenotypes, but no direct lifespan data is available. [References: Amor et al., 2024, Nature Aging, doi:10.1038/s43587-023-00560-5]" },
                healthspan: { score: 2, evidence: "Shown to be effective in ameliorating age-associated pathologies like liver fibrosis and metabolic dysfunction in mice. [References: Amor et al., 2020, Nature, doi:10.1038/s41586-020-2403-9]" },
                conservation: { score: 4, evidence: "Based on the conserved processes of cellular senescence and the adaptive immune system. [References: Ogrodnik et al., 2024, Cell, doi:10.1016/j.cell.2024.05.059]" },
                biomarkers: { score: 2, evidence: "No simple, non-invasive biomarker exists; assessment requires invasive tissue biopsies. [References: Ogrodnik et al., 2024, Cell, doi:10.1016/j.cell.2024.05.059]" },
                cost: { score: 1, evidence: "Expected to be prohibitively high; similar therapies (CAR T-cell) can cost over $500,000 per dose. [References: Hernandez et al., 2018, JAMA Oncology, doi:10.1001/jamaoncol.2018.0977]" }
            },
            "Nordihydroguaiaretic Acid (NDGA)": {
                human: { score: 1, evidence: "Non-existent for a geroscience indication. [References: Manda et al., 2020, Frontiers in Pharmacology, doi:10.3389/fphar.2020.00151]" },
                safety: { score: 1, evidence: "Concern; high doses may cause liver and kidney toxicity. [References: Lambert et al., 2002, Toxicon, doi:10.1016/S0041-0101(02)00203-9]" },
                lifespan: { score: 3, evidence: "NIA ITP studies showed 8-10% median lifespan extension in male mice, but highly sex-specific with no benefit in females. [References: Harrison et al., 2014, Aging Cell, doi:10.1111/acel.12170]" },
                healthspan: { score: 2, evidence: "Improved neuromuscular performance and physical function in both sexes. [References: Tezil et al., 2019, npj Aging and Mechanisms of Disease, doi:10.1038/s41514-019-0037-7]" },
                conservation: { score: 3, evidence: "Based on potent antioxidant/anti-inflammatory properties via conserved pathways (e.g., Nrf2/ARE) in mammals. [References: Rojo et al., 2012, Free Radical Biology and Medicine, doi:10.1016/j.freeradbiomed.2011.11.003]" },
                biomarkers: { score: 1, evidence: "No established biomarkers for its geroscience effects exist in humans. [References: Moqri et al., 2023, Cell, doi:10.1016/j.cell.2023.08.003]" },
                cost: { score: 2, evidence: "Likely inexpensive, but use is limited by safety concerns and lack of human data. [References: John et al., 2020, Current Cancer Drug Targets, doi:10.2174/1568009619666191022141547]" }
            },
            "Synthetic Tissues/Organs": {
                human: { score: 2, evidence: "Field is in its infancy; evidence is limited to specific applications like skin grafts and bladder augmentation. [References: Atala et al., 2006, The Lancet, doi:10.1016/S0140-6736(06)68438-9]" },
                safety: { score: 2, evidence: "Major concern; involves complex surgery with risks of infection and rejection. [References: Kuijer et al., 2007, Biomaterials, doi:10.1016/j.biomaterials.2007.06.003]" },
                lifespan: { score: 2, evidence: "Not a preventative intervention; a therapeutic approach to restore function, so lifespan extension is not a direct endpoint. [References: Mao et al., 2015, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.1508520112]" },
                healthspan: { score: 4, evidence: "Potentially immense benefit, as a new organ can restore function completely lost due to disease or aging. [References: Gallico et al., 1984, The New England Journal of Medicine, doi:10.1056/NEJM198408163110706]" },
                conservation: { score: 3, evidence: "Based on fundamental, conserved biological and cellular mechanisms of tissue engineering. [References: Langer et al., 1993, Science, doi:10.1126/science.8493529]" },
                biomarkers: { score: 3, evidence: "Function of a new organ can be measured precisely using standard clinical biomarkers. [References: McAllister et al., 2009, The Lancet, doi:10.1016/S0140-6736(09)60248-8]" },
                cost: { score: 1, evidence: "Prohibitively high due to complex, custom manufacturing and surgical procedures. [References: Jessop et al., 2015, Frontiers in Surgery, doi:10.3389/fsurg.2015.00052]" }
            },
            "Mitochondria (Elamipretide/SS-31)": {
                human: { score: 2, evidence: "Limited to specific rare diseases (e.g., Barth syndrome); primary endpoints have not always been met. [References: Thompson et al., 2021, Genetics in Medicine, doi:10.1038/s41436-020-01006-8]" },
                safety: { score: 3, evidence: "Strength; well-tolerated in trials, with the most common side effects being mild injection-site reactions. [References: Karaa et al., 2023, Neurology, doi:10.1212/WNL.0000000000207402]" },
                lifespan: { score: 2, evidence: "Lack of explicit lifespan data, but improves physiological function in aging mouse models. [References: Chiao et al., 2020, eLife, doi:10.7554/eLife.55513]" },
                healthspan: { score: 3, evidence: "Strong benefits in preclinical models, including improved cardiac and skeletal muscle function and rescued muscle force in aging mice. [References: Campbell et al., 2019, Free Radical Biology and Medicine, doi:10.1016/j.freeradbiomed.2018.12.031]" },
                conservation: { score: 4, evidence: "Highly conserved; targets cardiolipin in the inner mitochondrial membrane to stabilize cristae, reduce oxidative stress, and enhance ATP production. [References: Szeto, 2014, British Journal of Pharmacology, doi:10.1111/bph.12461]" },
                biomarkers: { score: 2, evidence: "Functional benefits in mice occurred without detectable changes in epigenetic or transcriptomic age, indicating these clocks do not measure its effect. [References: Mitchell et al., 2025, Aging Cell, doi:10.1111/acel.70026]" },
                cost: { score: 1, evidence: "Expected to be prohibitively high as an investigational drug requiring injection. [References: Sabbah, 2022, Cardiovascular Drugs and Therapy, doi:10.1007/s10741-021-10177-8]" }
            }
        };

        // Intervention data
        const interventions = [
            { name: "Acarbose", lifespan: 4, healthspan: 4, conservation: 4, human: 3, safety: 3, biomarkers: 4, cost: 5 },
            { name: "SGLT2 inhibitors", lifespan: 3, healthspan: 4, conservation: 4, human: 4, safety: 4, biomarkers: 4, cost: 3 },
            { name: "GLP-1 Receptor Agonists", lifespan: 3, healthspan: 4, conservation: 4, human: 4, safety: 4, biomarkers: 4, cost: 2 },
            { name: "L-deprenyl", lifespan: 4, healthspan: 3, conservation: 4, human: 3, safety: 4, biomarkers: 3, cost: 4 },
            { name: "Rapamycin/mTOR Inhibitors", lifespan: 4, healthspan: 4, conservation: 5, human: 3, safety: 3, biomarkers: 3, cost: 3 },
            { name: "Metformin", lifespan: 1, healthspan: 3, conservation: 5, human: 3, safety: 5, biomarkers: 4, cost: 5 },
            { name: "NAD+ Restoration (NMN/NR)", lifespan: 3, healthspan: 3, conservation: 5, human: 3, safety: 4, biomarkers: 4, cost: 3 },
            { name: "Glutathione Precursors (GlyNAC)", lifespan: 3, healthspan: 3, conservation: 4, human: 3, safety: 4, biomarkers: 3, cost: 4 },
            { name: "Gut Microbiome Modulation", lifespan: 3, healthspan: 3, conservation: 4, human: 3, safety: 4, biomarkers: 3, cost: 4 },
            { name: "Mitochondria (Urolithin A)", lifespan: 3, healthspan: 4, conservation: 4, human: 3, safety: 4, biomarkers: 3, cost: 3 },
            { name: "Autophagy Inducers (Spermidine)", lifespan: 3, healthspan: 4, conservation: 5, human: 2, safety: 4, biomarkers: 2, cost: 4 },
            { name: "Senolytics (Dasatinib + Quercetin)", lifespan: 3, healthspan: 4, conservation: 4, human: 3, safety: 3, biomarkers: 3, cost: 2 },
            { name: "Alpha-ketoglutarate (AKG)", lifespan: 3, healthspan: 3, conservation: 4, human: 2, safety: 4, biomarkers: 2, cost: 4 },
            { name: "Natural Senolytics (Fisetin)", lifespan: 3, healthspan: 3, conservation: 4, human: 2, safety: 4, biomarkers: 2, cost: 4 },
            { name: "Anti-Inflammatory Therapies", lifespan: 2, healthspan: 3, conservation: 4, human: 3, safety: 3, biomarkers: 4, cost: 4 },
            { name: "Epigenetic Reprogramming (OSK)", lifespan: 5, healthspan: 4, conservation: 4, human: 2, safety: 2, biomarkers: 4, cost: 1 },
            { name: "Plasma dilution/apheresis", lifespan: 2, healthspan: 3, conservation: 4, human: 3, safety: 3, biomarkers: 3, cost: 2 },
            { name: "Steroids (17α-estradiol)", lifespan: 4, healthspan: 3, conservation: 4, human: 1, safety: 3, biomarkers: 2, cost: 3 },
            { name: "Stem Cell Therapy", lifespan: 2, healthspan: 4, conservation: 4, human: 3, safety: 3, biomarkers: 2, cost: 1 },
            { name: "Xenotransplantation", lifespan: 4, healthspan: 4, conservation: 3, human: 2, safety: 2, biomarkers: 3, cost: 1 },
            { name: "Telomere Extension Therapies", lifespan: 3, healthspan: 3, conservation: 4, human: 2, safety: 2, biomarkers: 3, cost: 1 },
            { name: "Mitochondria (Elamipretide/SS-31)", lifespan: 2, healthspan: 3, conservation: 4, human: 2, safety: 3, biomarkers: 2, cost: 1 },
            { name: "Chemical Reprogramming", lifespan: 3, healthspan: 2, conservation: 4, human: 1, safety: 2, biomarkers: 4, cost: 2 },
            { name: "Chloroquine", lifespan: 2, healthspan: 2, conservation: 4, human: 2, safety: 2, biomarkers: 2, cost: 4 },
            { name: "Exosome Therapy", lifespan: 2, healthspan: 2, conservation: 3, human: 2, safety: 3, biomarkers: 2, cost: 2 },
            { name: "Synthetic Tissues/Organs", lifespan: 2, healthspan: 4, conservation: 3, human: 2, safety: 2, biomarkers: 3, cost: 1 },
            { name: "Gene Therapy", lifespan: 3, healthspan: 3, conservation: 4, human: 1, safety: 2, biomarkers: 3, cost: 1 },
            { name: "Young Blood Plasma and Parabiosis", lifespan: 2, healthspan: 3, conservation: 3, human: 2, safety: 2, biomarkers: 2, cost: 1 },
            { name: "Immunotherapy for Senescent Cells", lifespan: 2, healthspan: 2, conservation: 4, human: 1, safety: 2, biomarkers: 2, cost: 1 },
            { name: "Nordihydroguaiaretic Acid (NDGA)", lifespan: 3, healthspan: 2, conservation: 3, human: 1, safety: 1, biomarkers: 1, cost: 2 }
        ];

        const presets = {
            baseline: { lifespan: 20, healthspan: 10, conservation: 10, human: 20, safety: 20, biomarkers: 10, cost: 10 },
            regulator: { lifespan: 10, healthspan: 10, conservation: 0, human: 30, safety: 40, biomarkers: 0, cost: 10 },
            investor: { lifespan: 40, healthspan: 20, conservation: 0, human: 10, safety: 10, biomarkers: 10, cost: 10 },
            patient: { lifespan: 10, healthspan: 20, conservation: 0, human: 25, safety: 30, biomarkers: 0, cost: 15 }
        };

        const domainNames = {
            lifespan: "Preclinical Efficacy (Lifespan)",
            healthspan: "Preclinical Efficacy (Healthspan)", 
            conservation: "Mechanism Conservation",
            human: "Human Trial Evidence",
            safety: "Safety & Tolerability",
            biomarkers: "Biomarker Availability",
            cost: "Cost & Accessibility"
        };

        function showEvidence(interventionName, domain) {
            const modal = document.getElementById('evidenceModal');
            const title = document.getElementById('modalTitle');
            const domainTitle = document.getElementById('modalDomain');
            const body = document.getElementById('modalBody');

            title.textContent = interventionName;
            domainTitle.textContent = domainNames[domain];

            let content = `<div class="score-badge">Score: ${getInterventionScore(interventionName, domain)}/5</div>`;

            if (evidenceDatabase[interventionName] && evidenceDatabase[interventionName][domain]) {
                const data = evidenceDatabase[interventionName][domain];
                const parts = data.evidence.split(' [References: ');
                const evidenceText = parts[0];
                const references = parts[1] ? parts[1].replace(']', '') : null;
                
                content += `<p><strong>Evidence & Rationale:</strong></p>`;
                content += `<p>${evidenceText}</p>`;
                
                if (references) {
                    content += `<div class="references">`;
                    content += `<strong>References:</strong><br>`;
                    content += references.replace(/\.\]/g, '.').replace(/;/g, '<br>');
                    content += `</div>`;
                }
            } else {
                content += `<p><strong>Evidence & Rationale:</strong></p>`;
                content += `<p>Detailed evidence for this domain is being compiled. The score of ${getInterventionScore(interventionName, domain)}/5 is based on the comprehensive analysis in the research framework.</p>`;
                content += `<h4>Scoring Criteria for ${domainNames[domain]}:</h4>`;
                content += getScoreDescription(domain);
            }

            body.innerHTML = content;
            modal.style.display = 'block';
        }

        function getInterventionScore(interventionName, domain) {
            const intervention = interventions.find(i => i.name === interventionName);
            return intervention ? intervention[domain] : 'N/A';
        }

        function getScoreDescription(domain) {
            const descriptions = {
                lifespan: `<ul>
                    <li><strong>5:</strong> Consistent, significant (>10%) median lifespan extension in at least two mammalian species</li>
                    <li><strong>4:</strong> Consistent, significant (>10%) median lifespan extension in one mammalian species</li>
                    <li><strong>3:</strong> Significant (>5%) median lifespan extension in mice, may be sex-specific</li>
                    <li><strong>2:</strong> Significant extension in single study or only in invertebrates</li>
                    <li><strong>1:</strong> Inconsistent or modest effects, or negative evidence</li>
                </ul>`,
                human: `<ul>
                    <li><strong>5:</strong> High-certainty evidence from multiple large RCTs, FDA-approved for relevant indication</li>
                    <li><strong>4:</strong> Moderate-certainty evidence from large RCT or multiple smaller RCTs</li>
                    <li><strong>3:</strong> Low-certainty evidence from small RCTs on aging/healthspan endpoints</li>
                    <li><strong>2:</strong> Very low-certainty evidence from observational studies</li>
                    <li><strong>1:</strong> No human trials completed or planned</li>
                </ul>`,
                safety: `<ul>
                    <li><strong>5:</strong> FDA-approved for chronic use with decades of widespread use (>10M patients)</li>
                    <li><strong>4:</strong> Long-term use in large populations (>1M patients), well-known side effects</li>
                    <li><strong>3:</strong> Approved for chronic condition with well-understood safety profile</li>
                    <li><strong>2:</strong> Used clinically for acute/intermittent indication, significant but manageable side effects</li>
                    <li><strong>1:</strong> Significant safety concerns, high potential for severe side effects</li>
                </ul>`
            };
            return descriptions[domain] || '<p>Scoring criteria available in the full framework documentation.</p>';
        }

        function updateWeightDisplay(domain) {
            const value = document.getElementById(domain).value;
            document.getElementById(domain + '-value').textContent = value + '%';
            updateTotalWeight();
            calculateRankings();
        }

        function updateTotalWeight() {
            const domains = ['lifespan', 'healthspan', 'conservation', 'human', 'safety', 'biomarkers', 'cost'];
            const total = domains.reduce((sum, domain) => sum + parseInt(document.getElementById(domain).value), 0);
            
            document.getElementById('total-weight').textContent = `Total Weight: ${total}%`;
            document.getElementById('total-weight').style.color = total === 100 ? '#27ae60' : '#e74c3c';
            
            const warning = document.getElementById('warning');
            warning.style.display = total !== 100 ? 'block' : 'none';
        }

        function calculateRankings() {
            const weights = {
                lifespan: parseInt(document.getElementById('lifespan').value) / 100,
                healthspan: parseInt(document.getElementById('healthspan').value) / 100,
                conservation: parseInt(document.getElementById('conservation').value) / 100,
                human: parseInt(document.getElementById('human').value) / 100,
                safety: parseInt(document.getElementById('safety').value) / 100,
                biomarkers: parseInt(document.getElementById('biomarkers').value) / 100,
                cost: parseInt(document.getElementById('cost').value) / 100
            };

            const results = interventions.map(intervention => {
                const weightedScore = 
                    (intervention.lifespan * weights.lifespan) +
                    (intervention.healthspan * weights.healthspan) +
                    (intervention.conservation * weights.conservation) +
                    (intervention.human * weights.human) +
                    (intervention.safety * weights.safety) +
                    (intervention.biomarkers * weights.biomarkers) +
                    (intervention.cost * weights.cost);

                return { ...intervention, weightedScore };
            });

            results.sort((a, b) => b.weightedScore - a.weightedScore);

            const tbody = document.getElementById('ranking-tbody');
            tbody.innerHTML = '';

            results.forEach((intervention, index) => {
                const row = document.createElement('tr');
                if (index < 3) row.classList.add('top-3');

                row.innerHTML = `
                    <td class="rank-cell">${index + 1}</td>
                    <td class="intervention-cell">${intervention.name}</td>
                    <td class="score-cell" onclick="showEvidence('${intervention.name}', 'lifespan')">${intervention.lifespan}</td>
                    <td class="score-cell" onclick="showEvidence('${intervention.name}', 'healthspan')">${intervention.healthspan}</td>
                    <td class="score-cell" onclick="showEvidence('${intervention.name}', 'conservation')">${intervention.conservation}</td>
                    <td class="score-cell" onclick="showEvidence('${intervention.name}', 'human')">${intervention.human}</td>
                    <td class="score-cell" onclick="showEvidence('${intervention.name}', 'safety')">${intervention.safety}</td>
                    <td class="score-cell" onclick="showEvidence('${intervention.name}', 'biomarkers')">${intervention.biomarkers}</td>
                    <td class="score-cell" onclick="showEvidence('${intervention.name}', 'cost')">${intervention.cost}</td>
                    <td class="weighted-score-cell">${intervention.weightedScore.toFixed(2)}</td>
                `;
                tbody.appendChild(row);
            });
        }

        function setPreset(presetName) {
            const preset = presets[presetName];
            Object.keys(preset).forEach(domain => {
                document.getElementById(domain).value = preset[domain];
                updateWeightDisplay(domain);
            });
        }

        // Initialize
        document.addEventListener('DOMContentLoaded', function() {
            const domains = ['lifespan', 'healthspan', 'conservation', 'human', 'safety', 'biomarkers', 'cost'];
            domains.forEach(domain => {
                document.getElementById(domain).addEventListener('input', () => updateWeightDisplay(domain));
            });
            
            // Modal close functionality
            const modal = document.getElementById('evidenceModal');
            const closeBtn = document.getElementsByClassName('close')[0];
            
            closeBtn.onclick = function() {
                modal.style.display = 'none';
            }
            
            window.onclick = function(event) {
                if (event.target === modal) {
                    modal.style.display = 'none';
                }
            }
            
            updateTotalWeight();
            calculateRankings();
        });
    </script>
</body>
</html>
